Chi-Lun Ko
Overview
Explore the profile of Chi-Lun Ko including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
144
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang S, Huang Y, Chen Y, Tsai C, Ko C, Lin Y, et al.
Acta Cardiol Sin
. 2025 Jan;
41(1):55-71.
PMID: 39776923
This 2025 updated consensus outlines the diagnostic strategy for transthyretin amyloid cardiomyopathy (ATTR-CM). Given that ATTR-CM is a significant contributor to heart failure, this article emphasizes the importance of making...
2.
Hung Y, Yu A, Chen Y, Tsai C, Su M, Shun C, et al.
J Formos Med Assoc
. 2024 Oct;
PMID: 39389803
Background: RNA interference therapeutics reduce transthyretin production; however, their effect on hereditary transthyretin amyloid cardiomyopathy (ATTR-CA) remains unclear. We aimed to investigate alterations in technetium-99 m (Tc)-pyrophosphate (PYP) single-photon emission...
3.
Chuang P, Wang H, Tien Y, Chin W, Hsieh M, Chen C, et al.
Korean J Radiol
. 2024 Feb;
25(3):243-256.
PMID: 38413109
Objective: We aimed to investigate whether 2-[F]fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (2-[F]FDG PET/CT) can aid in evaluating the risk of malignancy in ampullary tumors detected by endoscopy. Materials And Methods:...
4.
Yu A, Chen Y, Tsai C, Wu Y, Su M, Chou C, et al.
J Am Heart Assoc
. 2024 Jan;
13(2):e030512.
PMID: 38214277
Background: Hereditary transthyretin amyloid cardiomyopathy (hATTR-CM) is a progressive and fatal disease. Recent evidence indicates that bone scintigraphy may serve as a tool to monitor the effectiveness of hATTR-CM treatment....
5.
Ko K, Ko C, Lee C, Cheng J, Wu Y, Hsu R, et al.
Circ Cardiovasc Imaging
. 2023 Jun;
16(6):e015034.
PMID: 37313753
Background: Cardiac allograft vasculopathy (CAV) is an obliterative and diffuse form of vasculopathy and is the most common cause of long-term cardiovascular mortality in heart transplant patients. This study aimed...
6.
Huang Y, Chen Z, Lee W, Wu C, Kuo P, Hsu H, et al.
Korean J Radiol
. 2023 Mar;
24(4):349-361.
PMID: 36907594
Objective: To quantitatively assess the pulmonary vasculature using non-contrast computed tomography (CT) in patients with chronic thromboembolic pulmonary hypertension (CTEPH) pre- and post-treatment and correlate CT-based parameters with right heart...
7.
Ko C, Lin S, Huang C, Chang Y, Ko K, Cheng M, et al.
Eur J Nucl Med Mol Imaging
. 2022 Sep;
50(2):376-386.
PMID: 36102963
Purpose: Deep learning (DL) models have been shown to outperform total perfusion deficit (TPD) quantification in predicting obstructive coronary artery disease (CAD) from myocardial perfusion imaging (MPI). However, previously published...
8.
Ko K, Yen R, Ko C, Chou S, Chang H, Yang Y, et al.
Clin Nucl Med
. 2021 Dec;
47(1):21-25.
PMID: 34874346
Purpose: This retrospective study aimed to determine the prognostic value of imaging parameters derived from midtherapy 18F-fluorodihydroxyphenylalanine (18F-DOPA) and 18F-FDG PET in pediatric patients with stage 3-4 neuroblastoma. Methods: We...
9.
Chuang P, Wang H, Lin Y, Chen C, Tien Y, Hsieh M, et al.
Eur Radiol
. 2021 Apr;
31(10):8040-8049.
PMID: 33864503
Objectives: We sought to investigate whether preoperative dual-phase 2-[F]FDG PET-CT identify predictors for poor survival in patients with ampullary carcinoma receiving pancreaticoduodenectomy. Methods: The preoperative PET-CT images of patients with...
10.
Lin T, Hsu P, Ko C, Kuo Y, Lu C, Shen C, et al.
Medicine (Baltimore)
. 2021 Apr;
100(15):e25557.
PMID: 33847685
The heterogeneity of brain perfusion is related to the risk factors of thromboembolic events such as antiphospholipid syndrome. However, the effectiveness of brain perfusion heterogeneity as a marker to predict...